Tag: phase

Latest News

VALBIOTIS : Autorisation de lancer l’étude clinique internationale de Phase II/III REVERSE-IT avec TOTUM-63, pour la réduction des facteurs de risque du diabète de type 2

Newsemia
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: VALBIOTIS (FR0013254851 – ALVAL, éligible PEA / PME), entreprise de Recherche et Développement engagée dans l’innovation scientifique, pour la prévention...
Cardiology

Hematopoietic stem-cell senescence and myocardial repair – Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.

Newsemia
Related Articles Hematopoietic stem-cell senescence and myocardial repair – Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic...
Biology

Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Panic Disorder

Newsemia
PORTLAND, Ore. (PRWEB) June 23, 2020 Nobilis Therapeutics, a biopharmaceutical company focused on the advancement of innovative CNS therapies, today announced that it has filed...
Gastroenterology

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection

Newsemia
JNJ-56136379 (JNJ-6379), a capsid assembly modulator that blocks hepatitis B virus (HBV) replication, was well tolerated and demonstrated dose-proportional pharmacokinetics in healthy participants in part...
Pharma / Biotech

Pharmacokinetic study (phase I-II) of a new dobutamine formulation in preterm infants immediately after birth.

Newsemia
Related Articles Pharmacokinetic study (phase I-II) of a new dobutamine formulation in preterm infants immediately after birth. Pediatr Res. 2020 Jul 01;: Authors: Pellicer A,...
Latest News

Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome

Newsemia
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple...
Neurology

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

Newsemia
AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced that detailed results of the phase 1 clinical program with...
Pharma / Biotech

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Newsemia
Related Articles Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Oncologist. 2020 Jun 16;: Authors: Harding JJ, Kelley...
Pharma / Biotech

First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjects.

Newsemia
Related Articles First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjects. Invest New...
Dentistry

Managing the phase down of amalgam among Nigerian dental professionals and students: A national survey.

Newsemia
Related Articles Managing the phase down of amalgam among Nigerian dental professionals and students: A national survey. Eur J Dent Educ. 2020 Jun 13;: Authors:...
Latest News

De nouvelles données de Phase II indiquent qu’un traitement combinant Truxima® (rituximab biosimilaire), lénalidomide et acalabrutinib (R2A) pourrait être efficace et bien toléré par les patients atteints d’un lymphome à cellules B agressif…

Newsemia
INCHEON, Corée du Sud–(BUSINESS WIRE)–  De nouvelles données de Phase II indiquent qu’un traitement combinant Truxima® (rituximab biosimilaire), lénalidomide et acalabrutinib (R2A) pourrait être efficace...
Latest News

IVERIC bio to Announce Zimura® 18 Month Data from the OPH2003 Phase 3 Clinical Trial in Geographic Atrophy Secondary to Age-Related Macular Degeneration and Host Conference Call on Monday, June 15, 2020

Newsemia
NEW YORK–(BUSINESS WIRE)–IVERIC announced that it will report 18 month data from the Zimura® Phase 3 clinical trial in geographic atrophy secondary to AMD on...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World